Pharma & Healthcare
Global Human Hepatitis B Immunoglobulin (HBIG) Market Research Report 2025
- Mar 11, 25
- ID: 7531
- Pages: 96
- Figures: 92
- Views: 10
The global market for Human Hepatitis B Immunoglobulin (HBIG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Hepatitis B Immunoglobulin (HBIG) include Baxter, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, China Biologic, Tiantan Biologic, Shuanglin Bio-pharmacy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Hepatitis B Immunoglobulin (HBIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Hepatitis B Immunoglobulin (HBIG).
The Human Hepatitis B Immunoglobulin (HBIG) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Hepatitis B Immunoglobulin (HBIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Hepatitis B Immunoglobulin (HBIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
Segment by Type
100IU/Bottle Human Hepatitis B Immunoglobulin
200IU/Bottle Human Hepatitis B Immunoglobulin
400IU/Bottle Human Hepatitis B Immunoglobulin
Segment by Application
Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Hepatitis B Immunoglobulin (HBIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Hepatitis B Immunoglobulin (HBIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Hepatitis B Immunoglobulin (HBIG) include Baxter, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, China Biologic, Tiantan Biologic, Shuanglin Bio-pharmacy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Hepatitis B Immunoglobulin (HBIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Hepatitis B Immunoglobulin (HBIG).
The Human Hepatitis B Immunoglobulin (HBIG) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Hepatitis B Immunoglobulin (HBIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Hepatitis B Immunoglobulin (HBIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
Segment by Type
100IU/Bottle Human Hepatitis B Immunoglobulin
200IU/Bottle Human Hepatitis B Immunoglobulin
400IU/Bottle Human Hepatitis B Immunoglobulin
Segment by Application
Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Hepatitis B Immunoglobulin (HBIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Hepatitis B Immunoglobulin (HBIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Human Hepatitis B Immunoglobulin (HBIG) Market Overview
1.1 Product Definition
1.2 Human Hepatitis B Immunoglobulin (HBIG) by Type
1.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2024 VS 2031)
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin
1.3 Human Hepatitis B Immunoglobulin (HBIG) by Application
1.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2024 VS 2031)
1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
1.3.3 Unexpected Crowd of Hepatitis B Infection
1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Estimates and Forecasts
1.4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue 2020-2031
1.4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales 2020-2031
1.4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Hepatitis B Immunoglobulin (HBIG) Market Competition by Manufacturers
2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Hepatitis B Immunoglobulin (HBIG), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Product Type & Application
2.7 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Date of Enter into This Industry
2.8 Global Human Hepatitis B Immunoglobulin (HBIG) Market Competitive Situation and Trends
2.8.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Hepatitis B Immunoglobulin (HBIG) Players Market Share by Revenue
2.8.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Scenario by Region
3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2020-2031
3.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2020-2025
3.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2026-2031
3.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020-2031
3.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020-2025
3.3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2026-2031
3.4 North America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.4.1 North America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.4.3 North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.5.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.5.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Region
3.6.1 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.7.1 Latin America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.7.3 Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2020-2031)
4.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2020-2025)
4.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2026-2031)
4.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2020-2031)
4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2020-2031)
4.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2020-2025)
4.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2026-2031)
4.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2020-2031)
4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2020-2031)
5.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2020-2025)
5.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2026-2031)
5.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2020-2031)
5.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2020-2031)
5.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2020-2025)
5.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2026-2031)
5.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2020-2031)
5.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Grifols Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 Octapharma
6.5.1 Octapharma Company Information
6.5.2 Octapharma Description and Business Overview
6.5.3 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.5.5 Octapharma Recent Developments/Updates
6.6 Shanghai RAAS
6.6.1 Shanghai RAAS Company Information
6.6.2 Shanghai RAAS Description and Business Overview
6.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.6.5 Shanghai RAAS Recent Developments/Updates
6.7 Hualan Biological
6.7.1 Hualan Biological Company Information
6.7.2 Hualan Biological Description and Business Overview
6.7.3 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.7.5 Hualan Biological Recent Developments/Updates
6.8 China Biologic
6.8.1 China Biologic Company Information
6.8.2 China Biologic Description and Business Overview
6.8.3 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.8.5 China Biologic Recent Developments/Updates
6.9 Tiantan Biologic
6.9.1 Tiantan Biologic Company Information
6.9.2 Tiantan Biologic Description and Business Overview
6.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.9.5 Tiantan Biologic Recent Developments/Updates
6.10 Shuanglin Bio-pharmacy
6.10.1 Shuanglin Bio-pharmacy Company Information
6.10.2 Shuanglin Bio-pharmacy Description and Business Overview
6.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.10.5 Shuanglin Bio-pharmacy Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Company Information
6.11.2 Sichuan Yuanda Shuyang Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 Boya Bio-pharmaceutical
6.12.1 Boya Bio-pharmaceutical Company Information
6.12.2 Boya Bio-pharmaceutical Description and Business Overview
6.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.12.5 Boya Bio-pharmaceutical Recent Developments/Updates
6.13 Shanghai Institute of Biological
6.13.1 Shanghai Institute of Biological Company Information
6.13.2 Shanghai Institute of Biological Description and Business Overview
6.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.13.5 Shanghai Institute of Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Hepatitis B Immunoglobulin (HBIG) Industry Chain Analysis
7.2 Human Hepatitis B Immunoglobulin (HBIG) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Hepatitis B Immunoglobulin (HBIG) Production Mode & Process Analysis
7.4 Human Hepatitis B Immunoglobulin (HBIG) Sales and Marketing
7.4.1 Human Hepatitis B Immunoglobulin (HBIG) Sales Channels
7.4.2 Human Hepatitis B Immunoglobulin (HBIG) Distributors
7.5 Human Hepatitis B Immunoglobulin (HBIG) Customer Analysis
8 Human Hepatitis B Immunoglobulin (HBIG) Market Dynamics
8.1 Human Hepatitis B Immunoglobulin (HBIG) Industry Trends
8.2 Human Hepatitis B Immunoglobulin (HBIG) Market Drivers
8.3 Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
8.4 Human Hepatitis B Immunoglobulin (HBIG) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Human Hepatitis B Immunoglobulin (HBIG) by Type
1.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2024 VS 2031)
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin
1.3 Human Hepatitis B Immunoglobulin (HBIG) by Application
1.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2024 VS 2031)
1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
1.3.3 Unexpected Crowd of Hepatitis B Infection
1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Estimates and Forecasts
1.4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue 2020-2031
1.4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales 2020-2031
1.4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Hepatitis B Immunoglobulin (HBIG) Market Competition by Manufacturers
2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Hepatitis B Immunoglobulin (HBIG), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Product Type & Application
2.7 Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Date of Enter into This Industry
2.8 Global Human Hepatitis B Immunoglobulin (HBIG) Market Competitive Situation and Trends
2.8.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Hepatitis B Immunoglobulin (HBIG) Players Market Share by Revenue
2.8.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Scenario by Region
3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2020-2031
3.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2020-2025
3.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2026-2031
3.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020-2031
3.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020-2025
3.3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2026-2031
3.4 North America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.4.1 North America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.4.3 North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.5.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.5.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Region
3.6.1 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.7.1 Latin America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.7.3 Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2020-2031)
4.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2020-2025)
4.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2026-2031)
4.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2020-2031)
4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2020-2031)
4.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2020-2025)
4.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2026-2031)
4.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2020-2031)
4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2020-2031)
5.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2020-2025)
5.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2026-2031)
5.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2020-2031)
5.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2020-2031)
5.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2020-2025)
5.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2026-2031)
5.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2020-2031)
5.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Grifols Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 Octapharma
6.5.1 Octapharma Company Information
6.5.2 Octapharma Description and Business Overview
6.5.3 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.5.5 Octapharma Recent Developments/Updates
6.6 Shanghai RAAS
6.6.1 Shanghai RAAS Company Information
6.6.2 Shanghai RAAS Description and Business Overview
6.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.6.5 Shanghai RAAS Recent Developments/Updates
6.7 Hualan Biological
6.7.1 Hualan Biological Company Information
6.7.2 Hualan Biological Description and Business Overview
6.7.3 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.7.5 Hualan Biological Recent Developments/Updates
6.8 China Biologic
6.8.1 China Biologic Company Information
6.8.2 China Biologic Description and Business Overview
6.8.3 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.8.5 China Biologic Recent Developments/Updates
6.9 Tiantan Biologic
6.9.1 Tiantan Biologic Company Information
6.9.2 Tiantan Biologic Description and Business Overview
6.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.9.5 Tiantan Biologic Recent Developments/Updates
6.10 Shuanglin Bio-pharmacy
6.10.1 Shuanglin Bio-pharmacy Company Information
6.10.2 Shuanglin Bio-pharmacy Description and Business Overview
6.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.10.5 Shuanglin Bio-pharmacy Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Company Information
6.11.2 Sichuan Yuanda Shuyang Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 Boya Bio-pharmaceutical
6.12.1 Boya Bio-pharmaceutical Company Information
6.12.2 Boya Bio-pharmaceutical Description and Business Overview
6.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.12.5 Boya Bio-pharmaceutical Recent Developments/Updates
6.13 Shanghai Institute of Biological
6.13.1 Shanghai Institute of Biological Company Information
6.13.2 Shanghai Institute of Biological Description and Business Overview
6.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
6.13.5 Shanghai Institute of Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Hepatitis B Immunoglobulin (HBIG) Industry Chain Analysis
7.2 Human Hepatitis B Immunoglobulin (HBIG) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Hepatitis B Immunoglobulin (HBIG) Production Mode & Process Analysis
7.4 Human Hepatitis B Immunoglobulin (HBIG) Sales and Marketing
7.4.1 Human Hepatitis B Immunoglobulin (HBIG) Sales Channels
7.4.2 Human Hepatitis B Immunoglobulin (HBIG) Distributors
7.5 Human Hepatitis B Immunoglobulin (HBIG) Customer Analysis
8 Human Hepatitis B Immunoglobulin (HBIG) Market Dynamics
8.1 Human Hepatitis B Immunoglobulin (HBIG) Industry Trends
8.2 Human Hepatitis B Immunoglobulin (HBIG) Market Drivers
8.3 Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
8.4 Human Hepatitis B Immunoglobulin (HBIG) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Hepatitis B Immunoglobulin (HBIG), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Product Type & Application
Table 12. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Hepatitis B Immunoglobulin (HBIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin (HBIG) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2020-2025)
Table 19. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2026-2031)
Table 21. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2020-2025)
Table 23. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2026-2031)
Table 25. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Type (2020-2025)
Table 51. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Type (2026-2031)
Table 52. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2020-2025)
Table 53. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2026-2031)
Table 54. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2020-2025)
Table 57. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2026-2031)
Table 58. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Application (2020-2025)
Table 61. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Application (2026-2031)
Table 62. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2020-2025)
Table 63. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2026-2031)
Table 64. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2020-2025)
Table 67. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2026-2031)
Table 68. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Baxter Human Hepatitis B Immunoglobulin (HBIG) Product
Table 74. Baxter Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. CSL Human Hepatitis B Immunoglobulin (HBIG) Product
Table 79. CSL Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Bayer Human Hepatitis B Immunoglobulin (HBIG) Product
Table 84. Bayer Recent Developments/Updates
Table 85. Grifols Company Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Grifols Human Hepatitis B Immunoglobulin (HBIG) Product
Table 89. Grifols Recent Developments/Updates
Table 90. Octapharma Company Information
Table 91. Octapharma Description and Business Overview
Table 92. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product
Table 94. Octapharma Recent Developments/Updates
Table 95. Shanghai RAAS Company Information
Table 96. Shanghai RAAS Description and Business Overview
Table 97. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product
Table 99. Shanghai RAAS Recent Developments/Updates
Table 100. Hualan Biological Company Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 104. Hualan Biological Recent Developments/Updates
Table 105. China Biologic Company Information
Table 106. China Biologic Description and Business Overview
Table 107. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 109. China Biologic Recent Developments/Updates
Table 110. Tiantan Biologic Company Information
Table 111. Tiantan Biologic Description and Business Overview
Table 112. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 114. Tiantan Biologic Recent Developments/Updates
Table 115. Shuanglin Bio-pharmacy Company Information
Table 116. Shuanglin Bio-pharmacy Description and Business Overview
Table 117. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product
Table 119. Shuanglin Bio-pharmacy Recent Developments/Updates
Table 120. Sichuan Yuanda Shuyang Company Information
Table 121. Sichuan Yuanda Shuyang Description and Business Overview
Table 122. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product
Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 125. Boya Bio-pharmaceutical Company Information
Table 126. Boya Bio-pharmaceutical Description and Business Overview
Table 127. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product
Table 129. Boya Bio-pharmaceutical Recent Developments/Updates
Table 130. Shanghai Institute of Biological Company Information
Table 131. Shanghai Institute of Biological Description and Business Overview
Table 132. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 134. Shanghai Institute of Biological Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Hepatitis B Immunoglobulin (HBIG) Distributors List
Table 138. Human Hepatitis B Immunoglobulin (HBIG) Customers List
Table 139. Human Hepatitis B Immunoglobulin (HBIG) Market Trends
Table 140. Human Hepatitis B Immunoglobulin (HBIG) Market Drivers
Table 141. Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
Table 142. Human Hepatitis B Immunoglobulin (HBIG) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Hepatitis B Immunoglobulin (HBIG)
Figure 2. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Type: 2024 & 2031
Figure 4. 100IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 5. 200IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 6. 400IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 7. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Application: 2024 & 2031
Figure 9. Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Figure 10. Unexpected Crowd of Hepatitis B Infection
Figure 11. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 12. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (2020-2031) & (K Pcs)
Figure 15. Global Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Pcs) & (2020-2031)
Figure 16. Human Hepatitis B Immunoglobulin (HBIG) Report Years Considered
Figure 17. Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Manufacturers in 2024
Figure 18. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Human Hepatitis B Immunoglobulin (HBIG) Players: Market Share by Revenue in Human Hepatitis B Immunoglobulin (HBIG) in 2024
Figure 20. Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 23. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 27. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2020-2031)
Figure 35. China Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 46. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2020-2031)
Figure 56. Global Revenue Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2020-2031)
Figure 57. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Application (2020-2031)
Figure 59. Global Revenue Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Application (2020-2031)
Figure 60. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2020-2031)
Figure 61. Human Hepatitis B Immunoglobulin (HBIG) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Hepatitis B Immunoglobulin (HBIG), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Product Type & Application
Table 12. Global Key Manufacturers of Human Hepatitis B Immunoglobulin (HBIG), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Hepatitis B Immunoglobulin (HBIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin (HBIG) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2020-2025)
Table 19. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2026-2031)
Table 21. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2020-2025)
Table 23. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2026-2031)
Table 25. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Type (2020-2025)
Table 51. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Type (2026-2031)
Table 52. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2020-2025)
Table 53. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2026-2031)
Table 54. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2020-2025)
Table 57. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2026-2031)
Table 58. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Application (2020-2025)
Table 61. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs) by Application (2026-2031)
Table 62. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2020-2025)
Table 63. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2026-2031)
Table 64. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2020-2025)
Table 67. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2026-2031)
Table 68. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Baxter Human Hepatitis B Immunoglobulin (HBIG) Product
Table 74. Baxter Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. CSL Human Hepatitis B Immunoglobulin (HBIG) Product
Table 79. CSL Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Bayer Human Hepatitis B Immunoglobulin (HBIG) Product
Table 84. Bayer Recent Developments/Updates
Table 85. Grifols Company Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Grifols Human Hepatitis B Immunoglobulin (HBIG) Product
Table 89. Grifols Recent Developments/Updates
Table 90. Octapharma Company Information
Table 91. Octapharma Description and Business Overview
Table 92. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product
Table 94. Octapharma Recent Developments/Updates
Table 95. Shanghai RAAS Company Information
Table 96. Shanghai RAAS Description and Business Overview
Table 97. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product
Table 99. Shanghai RAAS Recent Developments/Updates
Table 100. Hualan Biological Company Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 104. Hualan Biological Recent Developments/Updates
Table 105. China Biologic Company Information
Table 106. China Biologic Description and Business Overview
Table 107. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 109. China Biologic Recent Developments/Updates
Table 110. Tiantan Biologic Company Information
Table 111. Tiantan Biologic Description and Business Overview
Table 112. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 114. Tiantan Biologic Recent Developments/Updates
Table 115. Shuanglin Bio-pharmacy Company Information
Table 116. Shuanglin Bio-pharmacy Description and Business Overview
Table 117. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product
Table 119. Shuanglin Bio-pharmacy Recent Developments/Updates
Table 120. Sichuan Yuanda Shuyang Company Information
Table 121. Sichuan Yuanda Shuyang Description and Business Overview
Table 122. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product
Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 125. Boya Bio-pharmaceutical Company Information
Table 126. Boya Bio-pharmaceutical Description and Business Overview
Table 127. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product
Table 129. Boya Bio-pharmaceutical Recent Developments/Updates
Table 130. Shanghai Institute of Biological Company Information
Table 131. Shanghai Institute of Biological Description and Business Overview
Table 132. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 134. Shanghai Institute of Biological Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Hepatitis B Immunoglobulin (HBIG) Distributors List
Table 138. Human Hepatitis B Immunoglobulin (HBIG) Customers List
Table 139. Human Hepatitis B Immunoglobulin (HBIG) Market Trends
Table 140. Human Hepatitis B Immunoglobulin (HBIG) Market Drivers
Table 141. Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
Table 142. Human Hepatitis B Immunoglobulin (HBIG) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Hepatitis B Immunoglobulin (HBIG)
Figure 2. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Type: 2024 & 2031
Figure 4. 100IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 5. 200IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 6. 400IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 7. Global Human Hepatitis B Immunoglobulin (HBIG) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Application: 2024 & 2031
Figure 9. Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Figure 10. Unexpected Crowd of Hepatitis B Infection
Figure 11. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 12. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (2020-2031) & (K Pcs)
Figure 15. Global Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Pcs) & (2020-2031)
Figure 16. Human Hepatitis B Immunoglobulin (HBIG) Report Years Considered
Figure 17. Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Manufacturers in 2024
Figure 18. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Human Hepatitis B Immunoglobulin (HBIG) Players: Market Share by Revenue in Human Hepatitis B Immunoglobulin (HBIG) in 2024
Figure 20. Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 23. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 27. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2020-2031)
Figure 35. China Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 46. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2020-2031)
Figure 56. Global Revenue Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2020-2031)
Figure 57. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Application (2020-2031)
Figure 59. Global Revenue Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Application (2020-2031)
Figure 60. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Pcs) by Application (2020-2031)
Figure 61. Human Hepatitis B Immunoglobulin (HBIG) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232